Use of various nutritional support regimens in patients with transplanted hematopoietic stem cells


Cite item

Full Text

Abstract

Aim. To study the impact of modified nutritional support (NS) versus standard NS on therapy tolerability and posttransplantation in patients with oncohematological diseases.
Subjects and methods. Fifty-three patients, who had been diagnosed as acute myeloblastic (n = 19) or acute lymphoblastic (n = 16) leukemias, lymphomas (n = 10), and other oncohematological diseases (n = 8) and had received large-dose polychemotherapy followed by hematopoietic stem cell transplantation (HSCT), were prospectively examined.
The control group (n = 27) used standard NS (NS was prescribed when gastrointestinal (GI) events occurred; on day 1 after HSCT, the study group (n = 26) had modified NS added by glutamine dipeptide (0.57 g/kg/day). Energy demands were 35 kcal/kg/day; protein requirements were 1.5-1.7 g/kg/day. Artificial nutrition preparations were daily given through infusion pumps for 24 hours. In both groups, the criteria for NS discontinuation were natural assimilation of 60% of the required energy within 3 consecutive days or day 14 after HSCT when GI function was preserved.
Results. The patients receiving modified NS showed reductions in the incidence and severity of mucositis (p = 0.05), a less significant decrease in the laboratory and anthropometric indicators of nutritional status (p = 0.01), and a better hospital outcome on day 100 after HSCT (p = 0.01). There were no differences in the rate and severity of acute graft-versus-host reaction (p = 0.7%) and in one-year overall survival (p = 0.7%).
Conclusion. As compared with standard NS, modified NS enables a patient to sustain negative consequences of the conditioning regimen, HSCT in the early posttransplantation period.

About the authors

Maksim Anatol'evich Kucher

Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Email: doctorkucher@yandex.ru
Кафедра гематологии, трансфузиологии и трансплантологии- аспирант каф. гематологии, трансфузиологии и трансплантологии, Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова, тел. 8-812-233-29-25; Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Oleg Valer'evich Goloshchapov

Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Кафедра гематологии, трансфузиологии и трансплантологии- врач анестезиолог-реаниматолог, зав. отд-нием реанимации и интенсивной терапии, Институт детской гематологии и трансплантологии им. Р. М. Горбачевой, тел.: 8-812-233-29-25; Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Abdulbasir Abdurakhmanovich Ganapiev

Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Кафедра гематологии, трансфузиологии и трансплантологии; Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Boris Vladimirovich Afanas'ev

Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Кафедра гематологии, трансфузиологии и трансплантологии- д-р мед. наук, проф., зав. каф. гематологии, трансфузиологии и трансплантологии, Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова, дир. Института детской гематологии и трансплантологии им. Р. М. Горбачевой, тел.: 8-812-233-47-51; Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

M A Kucher

I.P. Pavlov Saint Petersburg State Medical University

I.P. Pavlov Saint Petersburg State Medical University

O V Goloshchapov

I.P. Pavlov Saint Petersburg State Medical University

I.P. Pavlov Saint Petersburg State Medical University

A A Ganapiyev

I.P. Pavlov Saint Petersburg State Medical University

I.P. Pavlov Saint Petersburg State Medical University

B V Afanasyev

I.P. Pavlov Saint Petersburg State Medical University

I.P. Pavlov Saint Petersburg State Medical University

References

  1. Muscaritoli M., Gricco G., Capria S. et al. Nutritional and metabolic support in patients undergoing bone marrow transplantation: Review article. Am. J. Clin. Nutr. 2002; 75(2): 183-190.
  2. Ballen K. K. New trends in umbilical cord blood transplantation. Blood 2005; 105: 3786-3792.
  3. Lipkin A. C., Lenssen P., Dickson B. S. Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr. Clin. Pract. 2005; 20(4): 423-439.
  4. Papadopoulou A., MacDonald A., Williams M. D. et al. Enteral nutrition after bone marrow transplantation. Arch. Dis. Childh. 1997; 77(2): 131-136.
  5. Arends J., Zuercher G., Dossettet A. et al. Non-surgical oncology - Guidelines on Parenteral Nutrition. German Med. Sci. 2009; 7: 1-14.
  6. Weisdorf S. A., Lysne J., Wind D. et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987; 43: 833- 838.
  7. Imataki O., Nakatani S., Hasegawa T. et al. Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Am. J. Hematol. 2006; 81: 747-752.
  8. Strasser S. I., McDonald G. B. Gastrointestinal and hepatic complications. In: Blume K. G., Forman S. J., Applebaum F. R., eds. Thomas Hematopoietic cell transplantation. 3-rd ed. Oxford: England Blackwell Publishing Ltd; 2004. 769-810.
  9. Ziegler T. R. Glutamine supplementation in bone marrow transplantation. Br. J. Nutr. 2002; 87: 9-15.
  10. Луфт В. М., Костюченко А. Л. Клиническое питание в интенсивной медицине: Практ. руководство. СПб.; 2002.
  11. Seashore J. H. Nutritional support of children in the intensive care unit. Yale J. Biol. Med. 1984; 57: 111-134.

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies